NEWS
Jun 04, 2025

A Statement Regarding Peptide Sourcing

ADVISORY BULLETIN

The SSRP is a medical education institute. We do not sell peptides. Our platform serves as a global scientific forum which promotes peptide science alongside cellular medicine education and clinical applications. It enables open dialogue and innovation through its support of the highest ethical and legal standards.

Our mission is to “improve patient outcomes, together”. This includes informing you how to protect both your patients and your license. Please take the time to discern the differences in peptide sourcing. This information is crucial for the safety of your patients, and the legal risks to you and your practice.

RUO Peptides

Some companies solicit research-use-only (RUO) peptides that exist outside human drug approval and/or prescription requirements. These products are for laboratory, educational, and investigational purposes only, not clinical, therapeutic, or diagnostic applications. They are labeled “not for human use” or “for research use only” as a legal disclaimer in an attempt to remove liability from the manufacturer in the context of human administration. Clinically prescribing or administering RUO peptides — even if they are third-party tested — violates federal and state board of pharmacy laws. The FDA sees this as misbranding and distribution of unapproved new drugs, and it’s legally indefensible in a court of law. Providers can get sued, have their license suspended, and face jail time for offering RUO meds directly from their clinics.

What If They Claim They’re Not RUO?

Even when a vendor claims their peptides are “pharma-grade” or “direct from manufacturer,” unless they are a licensed pharmacy, they are not legally authorized to sell medications for human use — and neither 3rd-party testing nor disclaimers remove this liability.

Compounded Peptides

If you have specific questions about how to source peptides appropriately, please reach out to your preferred compounding pharmacy. If you do not have one, we have several listed publicly on our website. Compounding pharmacies exist inside of a highly regulated, prescription drug supply chain. If you cannot find a particular peptide within their formulary, ask about substitutes they offer. If they do not ship to your state, ask your local compounding pharmacist how you can support them in their efforts to continue providing legitimate custom peptides for patients.

In Summary

Online injectable peptides that are not received from a legitimate compounding pharmacy are illegal. Period. Clinics can get raided, and providers can get shut down, if they are found to be prescribing them and storing them with intent to use clinically.

Compounding pharmacies compound drugs for human use for individually identified patients pursuant to a medical provider’s prescription. They ship directly to the patient, and patients’ rights to peptide therapy are protected under federal patient personal use laws.

Please consult with your legal counsel to ensure that, if you’re going to provide appropriate clinical guidance on peptide therapy, you’re doing so in a way that protects your patient’s health and your ability to continue to better ensure their safety.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
William Seeds, MD Jun 3, 2026
GLP-1 and the Gut–Musculoskeletal Axis: A Clinical Summary
The Overlooked Connection: Dysbiosis and Degenerative Disease Degenerative musculoskeletal diseases, including osteoarthritis (OA), osteoporosis (OP), sarcopenia (SP), and intervertebral disc degeneration (IVDD), affect well over a billion people globally and share three core pathological features: chronic inflammation, oxidative stress, and dysregulated cell death. What is increasingly clear, and clinically underappreciated, is that gut microbiota (GM) […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Jun 1, 2026
Ep. 090 - Dr. Seeds’ Office Hours - Bonus Episode
Preview Only
Dr. Seeds’ Office Hours – Episode 090

In this bonus episode from the MM15 Virtual Summit, Dr. Seeds addresses an important question around the use of GLP-1s for metabolic balancing in patients who do not need to lose weight. He shares his perspective on what may be considered microdosing, along with the clinical thought process he uses when determining appropriate dosing in these more nuanced cases.

Additional questions from the MM15 Virtual Summit can be found in our accompanying article here: [insert article link]

Access the full MM15 Course here: Mastermind 15 on Aesthetics

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
May 25, 2026
Ep. 089 - The Limits of Alternative Peptide Delivery
Preview Only
Dissecting Protocols – Episode 089

The Limits of Alternative Peptide Delivery

Dr. Seeds reviews oral, sublingual, and transdermal peptide delivery, and explains why subcutaneous injection remains the gold standard for most peptides. (Question Link)

Preview Only — Become a member for full access
GuardianMD May 21, 2026
SSRP Institute Welcomes GuardianMD as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [May 21, 2026] — The SSRP Institute announces that GuardianMD has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. GuardianMD is a healthcare services organization focused on physician collaboration and medical direction. It also provides telemedicine clearance services for healthcare practices. The company supports […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 18, 2026
Ep. 088 - A Deeper Look at the RAAS System
Preview Only
Rabbit Holes – Episode 088

A Deeper Look at the RAAS System

Dr. Seeds uses this Rabbit Holes episode to build on Journal Club Episode 87, revisiting the renin-angiotensin-aldosterone system and its broader role in cellular signaling. The discussion focuses on receptor balance, local tissue effects, and the mechanisms linking RAS disruption to inflammation, fibrosis, and mitochondrial stress.(Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
William Seeds, MD May 14, 2026
How the Peptide AOD-9604 Targets LanCL Proteins to Fight Viral Infections and Neurodegenerative Conditions 
In this research article, I return to the subject of my first-ever Journal Club (Ep. 017), in which I discussed a 2023 research study entitled, “Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection” (2023) that examined a specific growth hormone-derived peptide to address the underlying immunological mechanisms of post-viral […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
May 11, 2026
Ep. 087 - The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
Preview Only
Journal Club – Episode 087

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation

Dr. Seeds unpacks how RAS receptor balance drives inflammation, fibrosis, mitochondrial dysfunction, and tissue remodeling, far beyond its classical role in blood pressure regulation. (Article Link)

Preview Only — Become a member for full access
SSRP Institute May 6, 2026
Nutrition Education for Physicians and Medical Students
HEADLINE SCIENCE MAY 6, 2026 —Earlier in March, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Education announced an initiative to emphasize nutrition at the nation’s top medical schools. Reflecting U.S. Health and Human Services Secretary Robert Kennedy’s commitment to preventative medicine, this initiative will require “meaningful nutrition training” […]
READ NEWS
VIDEO
Cellular Medicine Mondays
May 4, 2026
Ep. 086 - May '26
Preview Only
SSRP Institute Apr 29, 2026
New ACC and AHA Cholesterol Management Guidelines
HEADLINE SCIENCE APRIL 29, 2026 – The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their cholesterol management guidelines, advocating for earlier and more aggressive intervention based on the understanding that cumulative lifetime exposure to high LDL-C drives atherosclerotic cardiovascular disease (ASCVD) risk. The guidelines aim to standardize care for dyslipidemia […]
READ NEWS

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.